You are currently viewing an archived document. A newly updated [2026 Premium Web/App Version] reflecting the latest policies and Verified guidelines is now available.
👉 Australia Home Guarantee Scheme 2026: 5% Deposit Rules, Price Caps & LMI SavingsWestern Australia has just opened applications for the Market Access Grant Scheme (MAGS) 2026, offering financial support for health and life-science businesses attending global trade events. 🩺✨ This initiative provides up to A$5,000 per company to help local innovators reach international markets and partnerships.
Announced on 5 November 2025, the program targets businesses ready to expand overseas and enhance their export potential. If your startup or SME operates in biotechnology, digital health, or medical devices, this could be your chance to grow beyond Australia. Let’s explore the details below 👇
Boosting WA Innovation through MAGS 2026
- Overview of the Market Access Grant Scheme 2026
- Eligibility Criteria and Priority Sectors
- 💡 How Can This Grant Benefit WA Startups and SMEs?
- How to Apply for the MAGS 2026 Funding
- Experience from Past Recipients
- Comparison with Other WA Funding Opportunities
- Summary of Key Points
- FAQ – Market Access Grant Scheme 2026
Overview of the Market Access Grant Scheme 2026
The Western Australian Government has launched MAGS 2026 to help local companies attend international conferences and trade shows. The scheme allocates up to A$100,000 in total funding, with a maximum of A$5,000 available per business.
It focuses on the health and medical life-sciences sector — including biotech, clinical research, pharma, and digital health solutions developed in WA. This sector represents one of the fastest-growing exports for the state, driven by demand for medical innovation and technology.
- Maximum grant per business: A$5,000
- Total pool: A$100,000
- Focus industry: Health & Medical Life Sciences
- Administered by: WA Government — Department of Jobs, Tourism, Science and Innovation (DJTSI)
Eligibility Criteria and Priority Sectors
To qualify, businesses must be based in Western Australia and actively engaged in export activities within the life-science sector. Applications will be assessed on their potential to expand market access and foster international collaboration.
Priority will be given to companies participating in major events such as BIO International Convention and MedTech Conferences in 2026. Each applicant must outline how the grant will support their export growth strategy and knowledge transfer.
- WA-registered life-science company
- Active export or market expansion plans
- Attendance at eligible international events in 2026
- Submission of detailed budget and expected outcomes
💡 How Can This Grant Benefit WA Startups and SMEs?
Participation in global trade events can be costly — travel, booth fees, and marketing expenses add up quickly. MAGS lightens this load, allowing WA startups to network with potential partners, investors, and research institutes worldwide. Many previous beneficiaries report increased funding opportunities and collaborations post-event.
Insight: According to the WA Government, companies that participated in international programs under previous rounds saw a 25 % rise in export contracts within a year. This underscores how targeted funding directly boosts innovation visibility abroad.
How to Apply for the MAGS 2026 Funding
Applications are now open through the Verified WA Government portal. Eligible businesses should prepare the following:
- Company profile and ABN details
- Event invitation or participation confirmation
- Budget and justification of expenses
- Expected business outcomes (export growth, partnerships, new markets)
Applications close on 31 January 2026. Early submission is recommended as funding is competitive and limited.
Experience from Past Recipients
WA-based MedTech startup BioWave Ltd shared that a previous round of MAGS funding helped them attend the 2024 BioKorea Conference. As a result, they secured two international distribution agreements worth A$1.2 million. This example shows how even modest grants can yield major returns for innovative SMEs.
Comparison with Other WA Funding Opportunities
| Program | Funding Limit | Focus Area |
|---|---|---|
| MAGS 2026 | Up to A$5,000 | Health & Medical Life Sciences |
| Innovation Voucher Program | Up to A$20,000 | General Innovation Support |
| Export Market Development Grant (EMDG) | Variable | All Export Industries |
Summary of Key Points
- WA Government offers A$5,000 per company for international event participation (Health & Life Sciences sector)
- Applications open now, close 31 Jan 2026
- Eligible businesses must be based in WA and active in export markets
- Administered by the Department of Jobs, Tourism, Science and Innovation (DJTSI)
- Verified details available at WA.gov.au
FAQ – Market Access Grant Scheme 2026
What is the Market Access Grant Scheme 2026?
It’s a WA Government program supporting life-science businesses to attend international events through A$5,000 grants.
Who can apply for the MAGS 2026 grant?
Eligible WA-based SMEs in biotech, medical devices, and digital health industries that plan to participate in international conferences or trade shows in 2026.
When is the application deadline?
Applications are open until 31 January 2026, or until funding runs out.
How do I submit my application?
Submit online via the Verified WA Government portal with required documents and budgets.
Why is this grant important for WA’s life-science sector?
It encourages innovation export and strengthens WA’s global presence in the medical and biotech industry.
